[1]
I. M. e Silva and E. A. Barbosa, “IMPACT OF SGLT2 INHIBITORS ON CARDIOVASCULAR OUTCOMES IN TYPE 2 DIABETES: A SYSTEMATIC REVIEW ”, REASE, vol. 12, no. 4, pp. 1–14, Apr. 2026, doi: 10.51891/rease.v12i4.25910.